Executive Director
Health Canada, Canada
Dr. Rosu-Myles is the Executive Director for the Centre for Oncology, Radiopharmaceuticals and Research and the Health Canada Director for the World Health Organization Collaborating Centre for the Standardization and Evaluation of Biologics. He manages a team who engage in cutting edge research and product evaluation and testing to support regulatory decisions on the authorization of clinical trials and market access for biologic and biosimilar oncology products, radiopharmaceuticals and novel product lines including cancer vaccines and cell and gene therapies. Dr. Rosu-Myles received his Ph.D. in Immunology and Microbiology from the University of Western Ontario and trained as a post-doctoral fellow at the National Cancer Institute in the US National Institutes of Health prior to being recruited to Health Canada to establish a stem cell research program in 2008. Since starting as Executive Director in 2018 Dr. Rosu-Myles has played a leadership role in the implementation of Health Canada’s response to the COVID-19 pandemic and in the development of their new Advanced Therapy Regulations.
Considerations for Global Harmonization and Accelerated Drug Development
Thursday, September 19, 2024
4:30 PM – 5:30 PM PDT